Sunshine Biopharma Inc (SBFM)
0.8074
-0.12
(-13.18%)
USD |
NASDAQ |
Apr 25, 16:00
0.805
0.00 (0.00%)
After-Hours: 20:00
Sunshine Biopharma Revenue (Quarterly): 7.680M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.680M |
| September 30, 2023 | 5.958M |
| June 30, 2023 | 5.561M |
| March 31, 2023 | 4.894M |
| December 31, 2022 | 3.940M |
| September 30, 2022 | 0.1328M |
| June 30, 2022 | 0.1503M |
| March 31, 2022 | 0.1226M |
| December 31, 2021 | 0.0851M |
| September 30, 2021 | 0.0504M |
| June 30, 2021 | 0.0529M |
| March 31, 2021 | 0.0401M |
| December 31, 2020 | 0.028M |
| September 30, 2020 | 0.0171M |
| June 30, 2020 | 0.0151M |
| March 31, 2020 | 0.0111M |
| December 31, 2019 | 0.0106M |
| September 30, 2019 | 0.0073M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.003M |
| March 31, 2019 | 0.0002M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 0.0912M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.0017M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.003M
Minimum
Jun 2019
7.680M
Maximum
Dec 2023
1.514M
Average
0.0529M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.25M |
| Total Expenses (Quarterly) | 8.867M |
| EPS Diluted (Quarterly) | -5.70 |
| Enterprise Value | -15.49M |
| Gross Profit Margin (Quarterly) | 33.44% |
| Profit Margin (Quarterly) | -16.28% |
| Earnings Yield | -2.44K% |
| Normalized Earnings Yield | -2439.84 |